Explosion at Chinese pharmaceutical plant leaves 10 dead

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Mputsylo)
(Image: Getty/Mputsylo)

Related tags: China, Qilu Tianhe Huishi Pharmaceuticals, Gsk

Dozens hurt and 10 people dead after an accident during renovation work in Shandong province, China.

The company involved, Qilu Tianhe Huishi Pharmaceuticals, had ordered maintenance work to be carried out on underground piping, which subsequently caused an explosion, according to local media reports​.

It was reported that welding of the piping caused a heat-transferring substance to ignite, causing an explosion and resulted in 10 workers dying of smoke inhalation, with a further 12 suffering minor injuries.

The local city government of Jinan are investigating the causes of the accident.

Qilu Tianhe specialises in the production of generic drugs and active pharmaceutical ingredients, with the company noting on its website that all of its products have passed the Chinese GMP standard.

The company involved did not respond to a request for comment.

In 2015​, a GlaxoSmithKline owned facility suffered an explosion in Tianjin, China. The situation led to the facility’s good manufacturing practice (GMP) certification being revoked by the UK’s regulatory body.

More recently, there was a national outcry after vaccines that were administered to children across the country were found to be improperly manufactured or substandard. The case led to a number of officials being dismissed​.

Related news

Show more

Related products

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

PatSnap | 15-Jun-2022 | Technical / White Paper

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Related suppliers

Follow us


View more